COVID-19: consider cytokine storm syndromes and immunosuppression.
作者信息
Mehta Puja, McAuley Daniel F, Brown Michael, Sanchez Emilie, Tattersall Rachel S, Manson Jessica J
机构信息
Centre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College London, London, UK.
Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK; Regional Intensive Care Unit, Royal Victoria Hospital, Belfast, UK.
出版信息
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
Abstract
摘要
相似文献
1
COVID-19: consider cytokine storm syndromes and immunosuppression.2019冠状病毒病：考虑细胞因子风暴综合征和免疫抑制。
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
2
Clinical findings in a patient with haemophilia A affected by COVID-19.一名甲型血友病患者感染新型冠状病毒肺炎的临床发现。
Haemophilia. 2020 Jul;26(4):e214-e216. doi: 10.1111/hae.14000. Epub 2020 Apr 13.
3
New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases.新型冠状病毒肺炎相关格林-巴利综合征对静脉注射免疫球蛋白高度敏感的新临床表现：两例意大利病例
Neurol Sci. 2020 Jul;41(7):1657-1658. doi: 10.1007/s10072-020-04484-5. Epub 2020 May 28.
4
Audio Interview: Capitalizing on Immune Responses to Covid-19.音频访谈：利用对新冠病毒的免疫反应
N Engl J Med. 2020 May 21;382(21):e93. doi: 10.1056/NEJMe2019020.
5
Old and new antirheumatic drugs for the treatment of COVID-19.用于治疗新型冠状病毒肺炎的新旧抗风湿药物
Joint Bone Spine. 2020 May;87(3):195-197. doi: 10.1016/j.jbspin.2020.03.013.
6
Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs.明智之战：炎症性风湿性疾病中的免疫抑制与免疫调节
Ann Rheum Dis. 2020 Aug;79(8):991-993. doi: 10.1136/annrheumdis-2020-218019. Epub 2020 Jun 11.
7
Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.主动疗法联合被动免疫疗法可能对对抗新冠病毒有效。
Clin Transl Sci. 2020 Sep;13(5):835-837. doi: 10.1111/cts.12816. Epub 2020 Jun 26.
8
Editorial: Information on the COVID-19 Pandemic continued.社论：关于新冠疫情的信息持续更新。
Transfus Apher Sci. 2020 Aug;59(4):102854. doi: 10.1016/j.transci.2020.102854. Epub 2020 Jun 26.
9
Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19.在一名伴有低丙种球蛋白血症和 COVID-19 的 MM 患者中，使用恢复期血浆成功地转移了抗 SARS-CoV-2 免疫。
Blood Adv. 2020 Oct 13;4(19):4864-4868. doi: 10.1182/bloodadvances.2020002595.
10
Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.2019冠状病毒病治疗的紧急途径：针对下游炎症以预防灾难性综合征。
Joint Bone Spine. 2020 May;87(3):191-193. doi: 10.1016/j.jbspin.2020.03.011.
引用本文的文献
1
Benefits and challenges: Qualitative exploration of women's experiences during the COVID-19 pandemic in Fiji.益处与挑战：斐济女性在新冠疫情期间经历的质性探索
PLoS One. 2025 Sep 4;20(9):e0331794. doi: 10.1371/journal.pone.0331794. eCollection 2025.
2
Single-cell transcriptomic atlas of blood and lung from mice infected with SARS-CoV-2 revealing distinct virulence characteristics between prototype and Omicron BA.1 strain.感染新冠病毒的小鼠血液和肺部单细胞转录组图谱揭示了原始毒株和奥密克戎BA.1毒株之间不同的毒力特征。
Virulence. 2025 Dec;16(1):2548931. doi: 10.1080/21505594.2025.2548931. Epub 2025 Aug 28.
3
Network Pharmacology and Experiment Verification-Based Strategy for Exploring the Mechanisms of Shuqing Granule in the Treatment of COVID-19.基于网络药理学和实验验证的疏清颗粒治疗新型冠状病毒肺炎作用机制探究策略
Pharmaceuticals (Basel). 2025 Aug 18;18(8):1216. doi: 10.3390/ph18081216.
4
A Machine Learning Approach to Understanding the Genetic Role in COVID-19 Prognosis: The Influence of Gene Polymorphisms Related to Inflammation, Vitamin D, and .一种用于理解基因在COVID-19预后中作用的机器学习方法：与炎症、维生素D相关的基因多态性的影响以及…… （原文最后不完整）
Int J Mol Sci. 2025 Aug 18;26(16):7975. doi: 10.3390/ijms26167975.
5
Dexamethasone chronotherapy of COVID-19 patients admitted to intensive care unit: an exploratory study.重症监护病房收治的COVID-19患者的地塞米松时间疗法：一项探索性研究。
BMC Infect Dis. 2025 Aug 27;25(1):1074. doi: 10.1186/s12879-025-11322-6.
6
Kinetics of anti-SARS-CoV-2 antibodies and hematological parameters in hospitalized pre-vaccination COVID-19 patients in Peru.秘鲁住院的未接种疫苗的新冠肺炎患者体内抗新冠病毒 2 型抗体的动力学及血液学参数
PeerJ. 2025 Aug 22;13:e19771. doi: 10.7717/peerj.19771. eCollection 2025.
7
Theoretical Framework and Methodological Approach for Investigating Potential Associations Between Long COVID and Autism Spectrum Disorder Prevalence.调查长新冠与自闭症谱系障碍患病率之间潜在关联的理论框架和方法学途径。
NeuroSci. 2025 Aug 13;6(3):80. doi: 10.3390/neurosci6030080.
8
Jing Guan Fang, an herbal formula, as an immunomodulator: opposing effects on basal and lipopolysaccharide-induced inflammation of macrophage via JAK/STAT3 and MAPK pathways.荆防方，一种中药配方，作为一种免疫调节剂：通过JAK/STAT3和MAPK途径对巨噬细胞的基础炎症和脂多糖诱导的炎症具有相反作用。
Front Pharmacol. 2025 Aug 6;16:1618488. doi: 10.3389/fphar.2025.1618488. eCollection 2025.
9
COVID-19 Organ Injury Pathology and D-Dimer Expression Patterns: A Retrospective Analysis.新型冠状病毒肺炎器官损伤病理学与D-二聚体表达模式：一项回顾性分析
Diagnostics (Basel). 2025 Jul 24;15(15):1860. doi: 10.3390/diagnostics15151860.
10
Acute transverse myelitis and associate vaccine complication in SARS-CoV-2 patients: a retrospective cohort analysis in real-world database.新型冠状病毒肺炎患者的急性横贯性脊髓炎及相关疫苗并发症：基于真实世界数据库的回顾性队列分析
Virol J. 2025 Aug 12;22(1):277. doi: 10.1186/s12985-025-02905-5.
本文引用的文献
1
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China.基于对来自中国武汉的150名患者数据的分析得出的COVID-19相关死亡的临床预测因素。
Intensive Care Med. 2020 May;46(5):846-848. doi: 10.1007/s00134-020-05991-x. Epub 2020 Mar 3.
2
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
3
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.巴瑞替尼作为2019新型冠状病毒急性呼吸道疾病的潜在治疗方法。
Lancet. 2020 Feb 15;395(10223):e30-e31. doi: 10.1016/S0140-6736(20)30304-4. Epub 2020 Feb 4.
4
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
5
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis.巨噬细胞活化综合征：导致脓毒症早期死亡的独特实体。
Front Immunol. 2019 Jan 31;10:55. doi: 10.3389/fimmu.2019.00055. eCollection 2019.
6
Pulmonary Involvement in Patients With Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症患者的肺部受累情况
Chest. 2016 May;149(5):1294-301. doi: 10.1016/j.chest.2015.11.004. Epub 2016 Jan 13.
7
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.白细胞介素-1受体阻断与具有巨噬细胞活化综合征特征的脓毒症患者死亡率降低相关：对一项既往III期试验的重新分析
Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402.
8
Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.HScore 的制定与验证：一种用于诊断反应性噬血细胞综合征的评分系统。
Arthritis Rheumatol. 2014 Sep;66(9):2613-20. doi: 10.1002/art.38690.
9
Adult haemophagocytic syndrome.成人噬血细胞性淋巴组织细胞增生症。
Lancet. 2014 Apr 26;383(9927):1503-1516. doi: 10.1016/S0140-6736(13)61048-X. Epub 2013 Nov 27.
Zotero 插件